Perhaps this Editor has attended too many new-company pitches of late, but there is another US ‘gold rush’ similar to EHRs (2009-12). This time, the gold glinting in the stream is reducing same-cause (disease) readmissions after the patient departs through the hospital doors. The latest prospector with pan, pick and shovel, quite amazingly, is Philips USA with the Transition to Ambulatory Care (eTrAC) (!) post-discharge program. Their first two applications, eCareCoordinator and eCareCompanion, just received FDA 510(k) clearance. (more…)